InsidersTradesSigma
Sino Biopharmaceutical Ltd. Stock: price and directors' dealings · Hong Kong · HKEX
Follow the Sino Biopharmaceutical Ltd. share price and the full insider trade history of the company, a listed equity based in Hong Kong. Shares are listed on HK HK, under the supervision of HKEX. Operating in the Health Care sector, Sino Biopharmaceutical Ltd. has logged 6 reports. Market capitalisation: €81.5bn. The latest transaction was disclosed on 30 April 2026 (Purchase). Among the most active insiders: Cheng Cheung Ling. All data is accessible without an account.
6
Insider Decl.
0
Thresholds
€8m
6 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Sino Biopharmaceutical Ltd. Strong Buy (bullish), based on 20 analysts. Average price target: HK$8.77.
15Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 7,235 of 26,270 companies
62.7
score / 100
Value56
Quality69
FCF yld8.1%
Earn yld2.5%
EV/EBITDA12.9x
ROE13%
Gross mgn82%
Net mgn7.4%
Debt/EBITDA1.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 30 April 2026
Declarations6 total
1,000,000 shares@ €0.59210.0006% mcap20.0% of flowShareXHKGHKEX:DA20260430E00374
Ideal exit: 25 Jan 2027 (T+270)
1,000,000 shares@ €0.59730.0006% mcap20.2% of flowShareXHKGHKEX:DA20260429E00338
Ideal exit: 24 Jan 2027 (T+270)
3,000,000 shares@ €0.59120.0019% mcap59.9% of flowShareXHKGHKEX:DA20260428E00209
Ideal exit: 23 Jan 2027 (T+270)
1,748,000 shares@ €0.6380.0012% mcap100.0% of flowShareXHKGHKEX:DA20260330E00223
Ideal exit: 25 Dec 2026 (T+270)
6 of 6 declarations